Table 1 Clinical characteristics of penicilliosis marneffei among patients with and without HIV infection
Variables | HIV-infected patients (N = 116) | HIV-uninfected patients (N = 34) | p-values |
|---|---|---|---|
Age (years) | 39 (32, 48.5) | 55 (50, 64) | <0.001 |
Female | 37 (31.9%) | 17 (50%) | 0.068 |
Body weight (kilograms) | 49 (42, 57) | 48 (40, 52) | 0.172 |
Underlying diseases* | 116 (100%) | 12 (35.3%) | <0.001 |
HIV | 116 (100%) | 0 (0) | |
Diabetes | 2 (1.7%) | 3 (8.8%) | |
Lymphoma | 0 | 2 (5.9%) | |
Colon cancer | 0 | 1 (2.9%) | |
Systemic lupus erythematosus | 0 | 6 (17.7%) | |
Mixed connective tissue disease | 0 | 1 (2.9%) | |
Myasthenia gravis | 0 | 1 (2.9%) | |
Receiving immunosuppressive drugs† | 0 | 6 (17.7%) | <0.001 |
Previous opportunistic infections or co-infections | 42 (36.2%) | 31 (91.2%) | <0.001 |
Cryptococcus neoformans | 3 (7.1%) | 0 | |
Mycobacterium tuberculosis | 23 (54.8%) | 3 (9.7%) | |
Pneumocystis jiroveci | 12 (28.6%) | 0 | |
Non tuberculous mycobacteria | 2 (4.8%) | 15 (48.4%) | |
Cytomegalovirus | 5 (11.9%) | 0 | |
Herpes zoster virus | 7 (16.7%) | 0 | |
Candida spp. | 2 (4.8%) | 0 | |
Isospora belli | 1 (2.4%) | 0 | |
Histoplasma capsulatum | 0 | 1 (3.2%) | |
Salmonella spp. | 0 | 8 (25.8%) | |
Rhodococcus equi | 0 | 1 (3.2%) |